Year: 2023
Type: article
Abstract: and CDC25C, and by inhibiting the c-Met-mTOR and JAK/STAT3 signaling pathways, reversing the methylation of RASSF1A gene, and activating TRAIL-R2/DR5 signal transduction.
Source: PubMed Central
Authors: Zhong-Ming Qian, Yun-Jin Chen, Yu-Xin Bao
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Award: G5445810262
OpenAlex ID: W4389452483
